View Information Collection (IC) List View Supporting Statement and Other Documents
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.


View ICR - OIRA Conclusion



0910-0116 198303-0910-011
Historical Active 198101-0910-001
HHS/FDA
GOOD MANUFACTURING PRACTICES FOR BLOOD AND BLOOD COMPONENTS
Revision of a currently approved collection   No
Regular
Approved without change 06/07/1983
Retrieve Notice of Action (NOA) 03/09/1983
APPROVED FOR SIX MONTHS. IN REVISING GMP REGULATIONS FOR BLOOD, FDA SHOULD EITHER ADOPT EXISTING RECORDKEEPING REQUIREMENTS ADOPTED BY THE AMERICAN ASSOCIATION OF BLOOD BANKS(AABB) OR EXEMPT AABB MEMBERS FROM THE FDA REQUIREMENTS. ONLY BY CHOOSING ONE OF THESE ALTERNATIVES WILL OMB CONSIDER FDA'S CORRECTION OF BURDEN AS VALID.
  Inventory as of this Action Requested Previously Approved
11/30/1983 11/30/1983 03/31/1983
12,000,040 0 12,000,040
3,000,000 0 3,000,000
0 0 0